Identification and validation of ecto-5' nucleotidase as an immunotherapeutic target in multiple myeloma.
Sign Up to like & getrecommendations! Published in 2022 at "Blood cancer journal"
DOI: 10.1038/s41408-022-00635-3
Abstract: Interaction of plasmacytoid dendritic cells (pDCs) with multiple myeloma (MM) cells, T- or NK-effector cells in the bone marrow (BM) microenvironment induces tumor cell growth, as well as inhibits innate and adaptive immune responses. Defining… read more here.
Keywords: nucleotidase immunotherapeutic; validation ecto; multiple myeloma; identification validation ... See more keywords